Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Boston Scientific Corporation
Boston Scientific Corporation News
Boston Scientific Corporation Quantitative Score
About Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Boston Scientific Corporation Earnings & Revenue
Boston Scientific Corporation Financials
Table Compare
Compare BSX metrics with: | |||
|---|---|---|---|
Earnings & Growth | BSX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | BSX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | BSX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | BSX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Boston Scientific Corporation Income
Boston Scientific Corporation Balance Sheet
Boston Scientific Corporation Cash Flow
Boston Scientific Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Boston Scientific Corporation Executives
| Name | Role |
|---|---|
| Mr. Michael F. Mahoney | Chairman, President & Chief Executive Officer |
| Mr. Daniel J. Brennan | Executive Vice President & Chief Financial Officer |
| Mr. Joseph M. Fitzgerald | Executive Vice President & Group President of Cardiology |
| Mr. Arthur Crosswell Butcher | Executive Vice President and Group President of MedSurg & Asia Pacific |
| Mr. Jeffrey B. Mirviss M.B.A. | Executive Vice President & President of Peripheral Interventions |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Michael F. Mahoney | Chairman, President & Chief Executive Officer | Male | 1965 | 4.83M |
| Mr. Daniel J. Brennan | Executive Vice President & Chief Financial Officer | Male | 1966 | 2.15M |
| Mr. Joseph M. Fitzgerald | Executive Vice President & Group President of Cardiology | Male | 1964 | 1.84M |
| Mr. Arthur Crosswell Butcher | Executive Vice President and Group President of MedSurg & Asia Pacific | Male | 1971 | 1.49M |
| Mr. Jeffrey B. Mirviss M.B.A. | Executive Vice President & President of Peripheral Interventions | Male | 1966 | 1.44M |
Boston Scientific Corporation Insider Trades
| Date | 1 Jul |
| Name | Brown Vance R |
| Role | SVP, GC and Corp. Secretary |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 4036 |
| Date | 1 Jul |
| Name | Brown Vance R |
| Role | SVP, GC and Corp. Secretary |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 1952 |
| Date | 1 Jul |
| Name | Brown Vance R |
| Role | SVP, GC and Corp. Secretary |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 4036 |
| Date | 1 Jul |
| Name | Carruthers Wendy |
| Role | EVP, Human Resources |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 3066 |
| Date | 1 Jul |
| Name | Carruthers Wendy |
| Role | EVP, Human Resources |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 1197 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 1 Jul | Brown Vance R | SVP, GC and Corp. Secretary | Acquired | M-Exempt | 4036 |
| 1 Jul | Brown Vance R | SVP, GC and Corp. Secretary | Disposed | F-InKind | 1952 |
| 1 Jul | Brown Vance R | SVP, GC and Corp. Secretary | Disposed | M-Exempt | 4036 |
| 1 Jul | Carruthers Wendy | EVP, Human Resources | Acquired | M-Exempt | 3066 |
| 1 Jul | Carruthers Wendy | EVP, Human Resources | Acquired | M-Exempt | 1197 |